Article
Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers.
Gastroenterology - 1 Aug 1999
Sinicrope F A, Lemoine M, Xi L, Lynch P M, Cleary K R, Shen Y, Frazier M L
Abstract excerpt
BACKGROUND & AIMS: Cyclooxygenase (COX) enzymes catalyze the conversion of arachidonic acid to prostaglandins. Evidence suggests that nonsteroidal anti-inflammatory drugs reduce the risk of colorectal cancer (CRC) and that this effect is mediated through COX inhibition. We analyzed and compared expression of the inducible COX-2 isoform in colorectal neoplasms from patients with hereditary nonpolyposis colorectal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
